20 June 2008 in Biochemical and Biophysical Research Communications
28 December 2020 in Proceedings of the National Academy of Sciences
Significance: The transcription factor p53 is a master tumor suppressor that controls the cellular response to genotoxic stress. Following DNA damage, p53 is activated by phosphorylation at multiple sites in the intrinsically disordered N-terminal transactivation domain. In particular, the phosphorylation status of Thr55 controls both activation and termination of p53-mediated transcriptional programs during different stages of the cellular DNA damage response. Here we show that Thr55 functions as a phosphorylation-dependent regulatory switch that modulates synergistic intramolecular interactions between the disordered transactivation domain and the structured DNA-binding domain. The strength of these interactions is fine-tuned by the intervening proline-rich domain and is enhanced by Thr55 phosphorylation, resulting in autoinhibition of p53 binding to promoters that regulate cell cycle arrest and apoptosis.
18 June 2018 in Proceedings of the National Academy of Sciences
Significance: Aggregation of amyloidogenic proteins is implicated in a number of debilitating human diseases. A mechanistic understanding of their aggregation behavior requires a quantitative description of the multistep equilibria involved in the self-assembly processes. Here we report the application of an integrative aggregation assay combining 19 F-NMR and turbidity measurements to reveal the kinetics and energetics of the human transthyretin aggregation pathway. A highly sensitive trifluoroacetyl probe enables direct observation and quantification of a weakly populated aggregation intermediate and reveals the importance of hydrophobic interactions for self-association. Extension of these studies to common pathogenic variants that are associated with early onset familial disease provides insights into the effect of the mutations on the kinetics and energetics of transthyretin aggregation.
24 July 2017 in Nature Chemical Biology
1 March 2021 in Biochemistry
Misfolding and aggregation of transthyretin (TTR) are linked to amyloid disease. Amyloidosis occurs when the TTR homotetramer dissociates into aggregation-prone monomers that self-assemble into amyloid. In familial transthyretin amyloidosis, hereditary amino acid substitutions destabilize TTR and promote aggregation. In this work, we used 19F nuclear magnetic resonance (NMR) to determine the effect of mutations in the EF helix (Y78F, K80D, K80E, and A81T) and EF loop (G83R and I84S) on the aggregation kinetics and stability of the TTR tetramer and monomer. The EF region acts as a scaffold that stabilizes interactions in both the strong and weak dimer interfaces of the tetramer and is the site of a cluster of pathogenic mutations. K80D and K80E are non-natural mutants that destabilize the EF helix and yield an equilibrium mixture of tetramer and monomer at neutral pH, providing a unique opportunity to determine the thermodynamic parameters for tetramer assembly under nondenaturing conditions. Of the pathogenic mutants studied, only A81T formed appreciable monomer at neutral pH. Real-time 19F NMR measurements showed that the pathogenic Y78F mutation accelerates aggregation by destabilizing both the tetrameric and monomeric species. The pathogenic mutations A81T, G83R, and I84S destabilize the monomer and increase its aggregation rate by disrupting a Schellman helix C-capping motif. These studies provide new insights into the mechanism by which relatively subtle mutations that affect tetramer or monomer stability promote entry of TTR into the dissociation–aggregation pathway.
16 March 2011 in Molecular BioSystems
Blocking the interaction between the E4 isoform of apolipoprotein E (ApoE) and amyloid beta-peptide (Aβ) may be an avenue for pharmacological intervention in Alzheimer's disease (AD). The main regions of interaction of the two proteins are, respectively, ApoE244–272 and Aβ12–28. These protein segments are too large to facilitate the design of small molecule inhibitors. We mapped the primary components of ApoE/Aβ interaction to smaller peptide segments. Within the three motifs that are primarily responsible for ApoE/Aβ interaction, we identified four peptides that substantially block ApoE/Aβ interaction and further improved their inhibitory activity by rational hydrophobic amino acid substitution. Moreover, the mapping results provide the clue that the Aβ residues which interact with ApoE appear to be in the same region where Aβ self-interacts. According to this information, we found that Congo Red and X-34 could strongly inhibit ApoE/Aβ interaction. Our findings extend our understanding of ApoE/Aβ interaction and may guide the discovery of inhibitors that treat AD by antagonizing ApoE/Aβ interaction.